Receptor for advanced glycation end products (RAGE) and its ligands: Focus on spinal cord injury

Juhyun Song, Won Taek Lee, Kyung Ah Park, Jong Eun Lee

Research output: Contribution to journalReview articlepeer-review

8 Citations (Scopus)


Spinal cord injury (SCI) results in neuronal and glial death and the loss of axons at the injury site. Inflammation after SCI leads to the inhibition of tissue regeneration and reduced neuronal survival. In addition, the loss of axons after SCI results in functional loss below the site of injury accompanied by neuronal cell body's damage. Consequently, reducing inflammation and promoting axonal regeneration after SCI is a worthy therapeutic goal. The receptor for advanced glycation end products (RAGE) is a transmembrane protein and receptor of the immunoglobulin superfamily. RAGE is implicated in inflammation and neurodegeneration. Several recent studies demonstrated an association between RAGE and central nervous system disorders through various mechanisms. However, the relationship between RAGE and SCI has not been shown. It is imperative to elucidate the association between RAGE and SCI, considering that RAGE relates to inflammation and axonal degeneration following SCI. Hence, the present review highlights recent research regarding RAGE as a compelling target for the treatment of SCI.

Original languageEnglish
Pages (from-to)13172-13191
Number of pages20
JournalInternational journal of molecular sciences
Issue number8
Publication statusPublished - 2014 Jul 25

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Receptor for advanced glycation end products (RAGE) and its ligands: Focus on spinal cord injury'. Together they form a unique fingerprint.

Cite this